15-51323419-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000103.4(CYP19A1):​c.-39+15076A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.566 in 151,706 control chromosomes in the GnomAD database, including 26,964 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 26964 hom., cov: 32)

Consequence

CYP19A1
NM_000103.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.319

Publications

10 publications found
Variant links:
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
CYP19A1 Gene-Disease associations (from GenCC):
  • aromatase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • aromatase excess syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.836 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP19A1NM_000103.4 linkc.-39+15076A>G intron_variant Intron 1 of 9 ENST00000396402.6 NP_000094.2 P11511-1A0A024R5S8Q8IYG4Q8TCA4
CYP19A1NM_001347248.1 linkc.-39+397A>G intron_variant Intron 1 of 9 NP_001334177.1 P11511-1A0A024R5S8
CYP19A1NM_031226.3 linkc.-39+397A>G intron_variant Intron 2 of 10 NP_112503.1 P11511-1A0A024R5S8Q05CU4A8K6W3Q8TCA4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP19A1ENST00000396402.6 linkc.-39+15076A>G intron_variant Intron 1 of 9 1 NM_000103.4 ENSP00000379683.1 P11511-1

Frequencies

GnomAD3 genomes
AF:
0.566
AC:
85782
AN:
151596
Hom.:
26892
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.843
Gnomad AMI
AF:
0.387
Gnomad AMR
AF:
0.589
Gnomad ASJ
AF:
0.434
Gnomad EAS
AF:
0.589
Gnomad SAS
AF:
0.512
Gnomad FIN
AF:
0.311
Gnomad MID
AF:
0.362
Gnomad NFE
AF:
0.443
Gnomad OTH
AF:
0.555
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.566
AC:
85914
AN:
151706
Hom.:
26964
Cov.:
32
AF XY:
0.560
AC XY:
41496
AN XY:
74076
show subpopulations
African (AFR)
AF:
0.843
AC:
34966
AN:
41454
American (AMR)
AF:
0.589
AC:
8991
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.434
AC:
1507
AN:
3470
East Asian (EAS)
AF:
0.590
AC:
3050
AN:
5168
South Asian (SAS)
AF:
0.511
AC:
2459
AN:
4808
European-Finnish (FIN)
AF:
0.311
AC:
3209
AN:
10308
Middle Eastern (MID)
AF:
0.354
AC:
102
AN:
288
European-Non Finnish (NFE)
AF:
0.443
AC:
30104
AN:
67942
Other (OTH)
AF:
0.559
AC:
1174
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1648
3295
4943
6590
8238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.478
Hom.:
11254
Bravo
AF:
0.604
Asia WGS
AF:
0.585
AC:
2032
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.53
DANN
Benign
0.28
PhyloP100
-0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2445761; hg19: chr15-51615616; API